Amylyx Pharmaceuticals (AMLX) Shareholder's Equity (2021 - 2026)
Amylyx Pharmaceuticals (AMLX) Shareholder's Equity (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.23 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 407.18 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.41 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.50 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.75 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 446.17 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.21 Bn |
| 10 | Amylyx Pharmaceuticals | 1.51 Bn | 1.51 Bn | - | 273.16 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 273.16 Mn |
| Dec 31, 2025 | 305.26 Mn |
| Sep 30, 2025 | 332.00 Mn |
| Jun 30, 2025 | 167.88 Mn |
| Mar 31, 2025 | 201.42 Mn |
| Dec 31, 2024 | 164.77 Mn |
| Sep 30, 2024 | 196.20 Mn |
| Jun 30, 2024 | 261.31 Mn |
| Mar 31, 2024 | 324.44 Mn |
| Dec 31, 2023 | 433.43 Mn |
| Sep 30, 2023 | 418.40 Mn |
| Jun 30, 2023 | 386.37 Mn |
| Mar 31, 2023 | 352.65 Mn |
| Dec 31, 2022 | 340.61 Mn |
| Sep 30, 2022 | 144.03 Mn |
| Jun 30, 2022 | 192.79 Mn |
| Mar 31, 2022 | 240.95 Mn |
| Dec 31, 2021 | -151.17 Mn |
| Sep 30, 2021 | -124.07 Mn |
| Jun 30, 2021 | -101.89 Mn |